ELITech's business focus is to become a leader in the IVD market by bringing better products and technologies to diagnostics and healthcare.
With the expansion of its capabilities through acquisitions and partnerships, the company has developed a strong product pipeline of diagnostic testing products and has gained recognition as a leader and partner in advanced diagnostics.
ELITech Molecular diagnostics products for the global IVD market include:
- MGB Alert and Q-PCR Alert real-time PCR reagents and kits which employ the company's proprietary Minor Groove Binder (MGB) technology for the detection and monitoring of serious infectious diseases and onco/hematology conditions
ELITech has inherited Nanogen’s strong intellectual property portfolio and licensing program, which includes MGB technology for real-time PCR testing setting a new benchmark for the detection of infectious diseases, including Herpetic and flu viruses.